 | • レポートコード：TPM-JL067 • 出版社/出版日：Transparency Market Research / 2019年5月20日 • レポート形態：英文、PDF、166ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、シロリムスの世界市場について調べ、シロリムスの世界市場規模、市場動向、市場シェア、市場環境、市場予測、用途別（臓器移植拒絶反応、リンパ管平滑筋腫症（LAM）、シロリムス被覆バルーンおよびカテーテル装置）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）分析、関連企業情報などをまとめました。 ・シロリムスの市場概要 ・シロリムスの市場動向 ・シロリムスの価格分析 ・シロリムスのサプライチェーン分析 ・シロリムスの世界市場規模・予測 ・シロリムス市場：用途別（臓器移植拒絶反応、リンパ管平滑筋腫症（LAM）、シロリムス被覆バルーンおよびカテーテル装置） ・シロリムス市場：流通チャネル別（病院薬局、小売薬局、オンライン薬局） ・地域別分析（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争環境・関連企業分析 |
Global Sirolimus Market: Overview
The global sirolimus market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on application, distribution channel, and region.
A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises a competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region, thereby presenting a thorough analysis of the overall competitive scenario in the global sirolimus market.
Global Sirolimus Market: Key Segments
In terms of application, the global sirolimus market has been segmented into organ transplant rejection, lymphangioleiomyomatosis (LAM), and sirolimus coated balloons & catheter devices.
Based on distribution channel, the market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment is anticipated to expand at a high CAGR during the forecast period.
The market has been analyzed based on price variations, technology trends, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year.
Global Sirolimus Market: Regional Outlook
In terms of region, the global sirolimus market has been segmented into North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, and Rest of Middle East & Africa).
The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Companies profiled in the global sirolimus market include Pfizer, Inc., Biocon, Dr. Reddy’s Laboratories Ltd., Concept Medical, Inc., Stentys SA, Torrent Pharmaceuticals Ltd., Zydus Cadila, and Intas Pharmaceuticals Ltd.
The global Sirolimus market has been segmented as follows:
Global Sirolimus Market, by Application
Organ Transplant Rejection
Lymphangioleiomyomatosis (LAM)
Sirolimus Coated Balloons & Catheter Devices
Global Sirolimus Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Sirolimus Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
Australia
India
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
South Africa
GCC Countries
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Sirolimus Market
4. Market Overview
4.1. Introduction
4.1.1. Application Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Sirolimus Market Analysis and Forecast, 2016–2026
5. Market Outlook
5.1.Disease Prevalence & Incidence Rate globally with key countries
5.2.Pipeline Analysis
5.3.Supply Chain Analysis
5.4.Pricing Analysis by Product & Manufacturers
5.5.Global Sirolimus Market, by Consumption Volume (Kg) (2018)
5.6.Overview of Sirolimus Manufacturing Process
6. Global Sirolimus Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Application, 2016–2026
6.3.1. Organ Transplant Rejection
6.3.2. Lymphangioleiomyomatosis (LAM)
6.3.3. Sirolimus Coating Balloon & Catheter Devices
6.4. Market Attractiveness, by Application
7. Global Sirolimus Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Distribution Channel, 2016–2026
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Pharmacies
7.4. Market Attractiveness, by Distribution Channel
8. Global Sirolimus Market Analysis and Forecasts, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Country/Region
9. North America Sirolimus Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Application, 2016–2026
9.2.1. Organ Transplant Rejection
9.2.2. Lymphangioleiomyomatosis (LAM)
9.2.3. Sirolimus Coating Balloon & Catheter Devices
9.3. Market Value Forecast, by Distribution Channel, 2016–2026
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Online Pharmacies
9.4. Market Value Forecast, by Country, 2016–2026
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By Distribution Channel
9.5.3. By Country
10. Europe Sirolimus Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2016–2026
10.2.1. Organ Transplant Rejection
10.2.2. Lymphangioleiomyomatosis (LAM)
10.2.3. Sirolimus Coating Balloon & Catheter Devices
10.3. Market Value Forecast, by Distribution Channel, 2016–2026
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Pharmacies
10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By Distribution Channel
10.5.3. By Country/Sub-region
11. Asia Pacific Sirolimus Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Application, 2016–2026
11.2.1. Organ Transplant Rejection
11.2.2. Lymphangioleiomyomatosis (LAM)
11.2.3. Sirolimus Coating Balloon & Catheter Devices
11.3.Market Value Forecast, by Distribution Channel, 2016–2026
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.4.Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By Distribution Channel
11.5.3. By Country/Sub-region
12. Latin America Sirolimus Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2016–2026
12.2.1. Organ Transplant Rejection
12.2.2. Lymphangioleiomyomatosis (LAM)
12.2.3. Sirolimus Coating Balloon & Catheter Devices
12.3. Market Value Forecast, by Distribution Channel, 2016–2026
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.4. Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By Distribution Channel
12.5.3. By Country/Sub-region
13. Middle East & Africa Sirolimus Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2016–2026
13.2.1. Organ Transplant Rejection
13.2.2. Lymphangioleiomyomatosis (LAM)
13.2.3. Sirolimus Coating Balloon & Catheter Devices
13.3. Market Value Forecast, by Distribution Channel, 2016–2026
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.4. Market Value Forecast, by Country/Sub-region, 2016–2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Israel
13.4.4. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By Distribution Channel
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis, by Company (2018)
14.3. Company Profiles
14.3.1. Pfizer, Inc.
14.3.2. Biocon
14.3.3. Dr. Reddy’s Laboratories Ltd.
14.3.4. Concept Medical, Inc.
14.3.7. Stentys SA
14.3.8. Torrent Pharmaceuticals Ltd.
14.3.9. Zydus Cadila
14.3.10. Intas Pharmaceuticals Ltd.
Table 01-10: Pipeline Analysis
Table 11: Global Sirolimus Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 12: Global Sirolimus Market Size (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 13: Global Sirolimus Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 14: North America Sirolimus Market Revenue (US$ Mn) Forecast, by Country, 2017–2027
Table 15: North America Sirolimus Market Revenue (US$ Mn) Forecast, by Application, 2017–2027
Table 16: North America Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 17: Europe Sirolimus Market Revenue (US$ Mn) Forecast, by Country, 2017–2027
Table 18: Europe Sirolimus Market Revenue (US$ Mn) Forecast, by Application, 2017–2027
Table 19: Europe Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 20: Asia Pacific Sirolimus Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Asia Pacific Sirolimus Market Revenue (US$ Mn) Forecast, by Application, 2017–2027
Table 22: Asia Pacific Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 23: Latin America Sirolimus Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 24: Latin America Sirolimus Market Revenue (US$ Mn) Forecast, by Application, 2017–2027
Table 25: Latin America Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2027
Table 26: Middle East & Africa Sirolimus Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 27: Middle East & Africa Sirolimus Market Revenue (US$ Mn) Forecast, by Application, 2017–2027
Table 28: Middle East & Africa Sirolimus Market Revenue (US$ Mn) Forecast, by Distribution Channel, 2017–2027